Based on results of the SEARCH and TODAY studies published nearly 5 years ago, clinicians treating youth with T2DM have known that treatment with metformin alone will likely be insufficient to decrease diabetes progression and reduce insulin requirements. The gene discussed is INS; the disease is type 2 diabetes mellitus.